Meridien Research participates in The Hero’s Journey Art Project

Meridien Research is participating in The Hero’s Journey Art Project, a nation-wide art program started by Eli Lilly to honor clinical trial participation and raise awareness of the importance of clinical research. 

Lilly has commissioned artist John Magnan to create three large wooden sculptures crafted from wooden bricks. Each brick is contributed by members of the clinical trials community: patients, their family and friends, medical teams, caregivers and researchers – like Meridien Research.

Decorated bricks that were sent to the artist will be permanently incorporated into the larger sculptures which will be publicly displayed at various locations in the United States.  The first sculpture, “Departure” was completed in early 2017 and was unveiled on March 10, 2017 at LiveSTRONG Headquarters

“All of the people who are contributing bricks have a unique and vital role to play in clinical research,” explained Meridien Research President and CEO, Anthony ‘Tony’ Busa, Jr. “It will be interesting to see what trial participants and researchers alike will contribute to these sculptures. Using art to educate others about research studies is a win-win for all involved.”

Meridien Research’s Site Director in St. Petersburg, Nicole Huff, felt compelled to participate in the project. “We have more than one subject who has come in here and stated that we saved their life, because they came into screen for a study and we found something else, sent them to see their Dr. or a specialist and had we not they would have died,” she explained. “I think it would be nice to share some of those stories. Those are the kinds of stories that need to be told about research.”

1500 brick kits were available with the expectation that about 1000 people would send their decorated wooden bricks to the artist.   A documentary film about the project is being produced in four parts and will be made available at

For more information about the project or Meridien Research’s clinical trials, please call 888-777-8839 or visit